Squarepoint’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$106K Sell
2024
Q1
$367K Buy
2023
Q4
$304K Buy
2023
Q3
$99.3K Sell
2023
Q2
$194K Buy
2023
Q1
Sell
2022
Q4
$123K Buy
2021
Q1
Sell
2020
Q4
$229K Buy
2020
Q3
Sell
2020
Q2
$363K Buy
2020
Q1
Sell
2019
Q4
$348K Buy